A fundraiser has been set up to help a Sanibel resident and member of the island and business community with her husband’s ...

NetworkNewsWire Editorial Coverage NEW YORK, July 7, 2025 /PRNewswire/ -- An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people ...

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year ...

Every bladder cancer journey is different, and no single treatment or diagnostic path fits everyone. According to patients who have experienced bladder cancer, the best care for you will depend on ...

CG Oncology, Inc. (NASDAQ:CGON) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 17, ...

UroGen Pharma Ltd. (NASDAQ: URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen ...

Furthermore, objective response rate of subgroups in liver metastasis, bladder cancer and tumor with negative expression of Nectin-4 were 88.2%, 94.4%, 100%, respectively. This demonstrates that ...

Second-look TURBT showed limited value in altering outcomes for high-grade Ta bladder cancer after complete resection.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

(Alliance News) - AstraZeneca PLC on Friday said Imfinzi is "poised to transform the standard of care" as it reported the bladder cancer treatment cleared a European regulatory milestone.

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.